APIC Offers Business Case for Infection Prevention Conference
The Association for Professionals in Infection Control and Epidemiology (APIC) will hold its "Building an Effective Business Case for Infection Prevention" conference Sept. 12-13, 2010 in Baltimore, Md.
The Association for Professionals in Infection Control and Epidemiology (APIC) will hold its "Building an Effective Business Case for Infection Prevention" conference Sept. 12-13, 2010 at the Baltimore Waterfront Marriott in Baltimore, Md.
This interactive, hands-on workshop is designed specifically for experienced infection preventionists. Attendees will learn how to develop and use strategies, tools and templates to make a compelling business case for effective infection prevention and control programs, including how to convince healthcare administrators of the need for additional infection prevention resources.
Participants will learn how to:
-- Use and customize the APIC HAI Cost Calculator Tool to estimate the cost of infections in their own institution
-- Interpret the results of statistical models
-- Build a customized business case and effectively present it to healthcare administrative leadership
-- Create a compelling proposal to increase resources for infection prevention and control
-- Market accomplishments and demonstrate value
To register, CLICK HERE.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
Robust infectious disease surveillance, including rapid subtyping of influenza A, is essential for early detection, containment, and public health reporting of novel viral threats.
